title: Hematopoietic colony-stimulating factors for neutropenic patients in the ICU.
abstract: OBJECTIVE
  To assess whether adjunct hematopoietic colony-stimulating factor (H-CSF) accelerates neutrophil recovery and improves survival.
  
  
  METHODS
  A retrospective study.
  
  
  METHODS
  Medical/surgical intensive care unit (ICU).
  
  
  METHODS
  30 neutropenic patients admitted to the ICU and treated with H-CSF. Controls were the preceding 30 neutropenic patients not treated with H-CSF.
  
  
  RESULTS
  Patient admission characteristics were reviewed. Endpoints were neutrophil recovery ( > 1.0 x 10(9)/l), length of ICU stay and survival. Depth and duration of neutropenia (0.267 +/- 0.04 x 10(9)/l for 12 +/- 1.7 days vs 0.293 +/- 0.05 x 10(9)/l for 15 +/- 1.9 days; p = 0.67 and 0.21), and the Acute Physiology and Chronic Health Evaluation II and organ system failure scores were similar. Systemic candidiasis was lower in the H-CSF group (20 vs 3 %; p > 0.05). In 11 (36.6 %) and 10 (33.3 %) patients neutrophil count recovered ( > 1.0 x 10(9)/l); H-CSF did not reduce the duration of neutropenia (7.8 +/- 1.4 vs 5.7 +/- 1.3 days; p = 0. 28), the length of ICU stay (7.8 +/- 1.1 vs 8.9 +/- 1.5 days; p = 0. 55) or improve survival (23 vs 10 %; p = 0.168).
  
  
  CONCLUSIONS
  H-CSF for treatment of neutropenia in patients admitted to the ICU did not accelerate neutrophil recovery or improve survival.
authors.affiliation: Medicine Department (MBC 46), King Faisal Specialist Hospital + Research Centre, P. O. Box 3354, Riyadh 11211, Saudi Arabia. abouchama@hotmail.com
authors.forename: A
authors.initials: A
authors.lastname: Bouchama
authors.forename: B
authors.initials: B
authors.lastname: Khan
authors.forename: W
authors.initials: W
authors.lastname: Djazmati
authors.forename: K
authors.initials: K
authors.lastname: Shukri
mesh_terms: D018806:APACHE; D000328:Adult; D003422:Critical Care / Q000379:methods*; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009503:Neutropenia / Q000097:blood / Q000188:drug therapy*; D009504:Neutrophils / Q000166:cytology; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor